Trial Profile
A open-lable,single arm and exploratory clinical trail of Apatinib for first-line Maintenance treatment of advanced colorectal cancer.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 Sep 2017 New trial record